搜索结果
疾病ID:TCMBANKDI015367
疾病名:Multiple Sclerosis, Relapsing-Remitting
MeSH_Name:Immune System Diseases; Nervous System Diseases
HPO_Name:-
UMLS_Name:Disease or Syndrome
DO_Name:disease of anatomical entity
疾病类型:disease
DisGeNET_Link:C0751967
MeSH_Link:C20; C10
HPO_Link:-
UMLS_Link:T047
DO_Link:DOID:7
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN058519 | (-)-epigallocatechin-3-gallate; (-)-epigallocatechin 3-o-gallate;epigallocatechin gallate; galloyl-l-epigallocatechol; epigallocatechin 3-gallate; (-)-epigallocatechin gallate; | KBio2_000796; SpecPlus_000277; 50299_FLUKA; Spectrum3_000244; KBioGR_002002; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester; MLS000758300; DivK1c_006373; (−)-Epigallocatechin gallate; EGCG; SPBio_000035; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; KBioSS_000796; Epigallocatechin gallate; Spectrum4_001541; (-)-epigallocatechin 3-gallate; Tea catechin; AIDS000674; KBio2_005932; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester; KBio1_001317; 989-51-5; AIDS-000674; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); KBio2_003364; Galloyl-L-epigallocatechol; SDCCGMLS-0066550.P001; (-)-Epigallocatechol gallate; ACon1_001054; Spectrum5_000102; Green tea extract; MEGxp0_001166; C09731; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; CCRIS 3729; Teavigo; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Spectrum2_000168; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate; CHEBI:4806; (-)-epigallocatechin-3-gallate ; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; SPECTRUM210239; E4143_SIAL; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; Spectrum_000316; (-)-EGCG; KBio3_001128; BSPBio_001628; Epigallocatechol, 3-gallate, (-)-; Epigallocatechin-3-gallate; E4268_SIAL; epigallocatechin gallate ; epigallocatechin-3-gallate; (-)epigallocatechin-3-gallate ; EGCG; 989E515; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; HMS2051K21; CS-1258; AC1L22IG; AK165605; Green tea polyphenols, Anagen; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; AKOS015918182; CAS-989-51-5; Epigallocatechin gallate, primary pharmaceutical reference standard; W-5069; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; (-)-Epigallocatechin gallate, analytical standard; Q-100914; DSSTox_RID_78830; AN-15867; DSSTox_GSID_29889; (-)-Epigallocatechol gallate; FT-0604392; NCGC00164319-04; Green tea extract; MEGxp0_001166; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; N1874; CHEBI:4806; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; BG00814299; HMS3649E08; D0E9DB; Epigallocatechol, 3-gallate, (-)-; (-)-EpigallocatechinGallateHydrate; Epigallocatechin-3-gallate; AB0014381; BQM438CTEL; NC00078; ST51055716; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; SpecPlus_000277; Spectrum3_000244; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; MLS000758300; (-)-Epigallocatechin gallate (EGCG); CCG-38378; Gallic acid, 3-ester with epigallocatechol, (-)-; SR-01000946601-1; NCGC00164319-01; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; NCGC00164319-06; DSSTox_CID_567; MCULE-3341525983; Epigallocatechin monogallate, B; Tox21_303457; SAM001247031; 4awm; K791; 989-51-5; SR-01000946601; MFCD00075940; EGCG analogs; Galloyl-L-epigallocatechol; NCGC00164319-03; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Spectrum5_000102; CPD000449288; (-)-Epigallocatechin gallate; LMPK12030005; E0694; Teavigo; Epigallocatechin gallate analogs, Anagen; Epigallocatechin-3-monogallate; ACN-035233; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Sunphenon; Epigallocatechin gallate(EGCG); s2250; PF-EGCg 90; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate; 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; MLS001424000; (-)-EGCG; ZINC3870412; KBio2_000796; EGCG cpd; KBioGR_002002; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; EGCG, Anagen; NCGC00257243-01; Tox21_201468; L-Epigallocatechin gallate; cid_65064; SPBio_000035; BG01747388; Epigallocatechin gallate; KBioSS_000796; Spectrum4_001541; (-)-epigallocatechin 3-gallate; DB12116; EPIGALOCATECHIN GALLATE; ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE; KBio2_005932; I14-7747; D0U2BH; MCULE-7760530136; 2kdh; Epigallocatechin gallate, Anagen; AOB2839; SDCCGMLS-0066550.P001; 863-65-0; FR-109; ST097428; ACon1_001054; LS-2197; CCRIS 3729; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Epigallocate; GTPL7002; BDBM50070942; C22H18O11; GTPs,Anagen; SCHEMBL35258; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; MolPort-001-741-358; DivK1c_006373; KB-206444; SR-01000759328; Teavigo;; EGCG; (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT); HY-13653; (-)-Epigallocatechin gallate, >=95%; NCGC00259019-01; Tea catechin; DS-9030; SR-01000759328-6; SR-01000759328-5; KDH; AC1Q5X0Z; KBio1_001317; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); NVP-XAA 723; KBio2_003364; EBD2138593; FT-0082796; NCGC00164319-02; C09731; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; UNII-BQM438CTEL; DTXSID1029889; WMBWREPUVVBILR-WIYYLYMNSA-N; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epigallocatehin gallate; Spectrum2_000168; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; (-)-Epigallocatechin gallat; SPECTRUM210239; Epigallocic acid; Epigallocatcchin Gallate; KS-0000132O; BP-30205; CHEMBL297453; SC-47284; Spectrum_000316; 3oob; (-)-Epigallocatechin gallate, >=97.0% (HPLC); KBio3_001128; BSPBio_001628; epigallo-catechin gallate | C22H18O11 | 458.4g/mol | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE001811 | PTHLH | BDE2; HHM; PLP; PTHR; PTHRP | parathyroid hormone like hormone |
| TCMBANKGE011761 | MBP | - | myelin basic protein |
| TCMBANKGE010111 | LRRC32 | D11S833E; GARP | leucine rich repeat containing 32 |
| TCMBANKGE003005 | CYP24A1 | CP24; CYP24; HCAI; HCINF1; P450-CC24 | cytochrome P450 family 24 subfamily A member 1 |
| TCMBANKGE000250 | CCL5 | D17S136E; RANTES; SCYA5; SIS-delta; SISd; TCP228; eoCP | C-C motif chemokine ligand 5 |
| TCMBANKGE014824 | TNFSF15 | TL1; TL1A; TNLG1B; VEGI; VEGI192A | TNF superfamily member 15 |
| TCMBANKGE000176 | RRN3 | A-270G1.2; TIFIA | RRN3 homolog, RNA polymerase I transcription factor |
| TCMBANKGE000562 | IL18 | IGIF; IL-18; IL-1g; IL1F4 | interleukin 18 |
| TCMBANKGE014832 | DHCR24 | DCE; Nbla03646; SELADIN1; seladin-1 | 24-dehydrocholesterol reductase |
| TCMBANKGE002185 | BMP5 | - | bone morphogenetic protein 5 |
| TCMBANKGE001514 | TLR7 | TLR7-like | toll like receptor 7 |
| TCMBANKGE000144 | POU5F1P3 | OCT3; OCT4; OCT4-pg3; OTF-3; OTF3; OTF3L; Oct-3; Oct-4; POU5F1; POU5F1L; POU5FLC12 | POU class 5 homeobox 1 pseudogene 3 |
| TCMBANKGE006904 | MBTPS1 | PCSK8; S1P; SEDKF; SKI-1 | membrane bound transcription factor peptidase, site 1 |
| TCMBANKGE004754 | TOR2A | TORP1 | torsin family 2 member A |
| TCMBANKGE000369 | IFNA1 | IFL; IFN; IFN-ALPHA; IFN-alphaD; IFNA13; IFNA@; leIF D | interferon alpha 1 |
| TCMBANKGE009014 | MS4A1 | B1; Bp35; CD20; CVID5; LEU-16; MS4A2; S7 | membrane spanning 4-domains A1 |
| TCMBANKGE009307 | ERVK-18 | HERV-K18; PR; Protease; Proteinase; c1_C; env | endogenous retrovirus group K member 18 |
| TCMBANKGE004616 | RBM45 | DRB1; RB-1 | RNA binding motif protein 45 |
| TCMBANKGE010096 | CARD16 | COP; COP1; PSEUDO-ICE | caspase recruitment domain family member 16 |
| TCMBANKGE013010 | COX2 | COII; MTCO2 | cytochrome c oxidase subunit II |
| TCMBANKGE005671 | IL11 | AGIF; IL-11 | interleukin 11 |
| TCMBANKGE012222 | IFNA13 | - | interferon alpha 13 |
| TCMBANKGE000486 | IL2RA | CD25; IDDM10; IL2R; IMD41; TCGFR; p55 | interleukin 2 receptor subunit alpha |
| TCMBANKGE014985 | PTH | FIH1; PTH1 | parathyroid hormone |
| TCMBANKGE001052 | NLRP3 | AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1 | NLR family pyrin domain containing 3 |
| TCMBANKGE009975 | LAMC2 | B2T; BM600; CSF; EBR2; EBR2A; LAMB2T; LAMNB2 | laminin subunit gamma 2 |
| TCMBANKGE000871 | IGFBP3 | BP-53; IBP3 | insulin like growth factor binding protein 3 |
| TCMBANKGE009684 | CNGB1 | CNCG2; CNCG3L; CNCG4; CNG4; CNGB1B; GAR1; GARP; GARP2; RCNC2; RCNCb; RCNCbeta; RP45 | cyclic nucleotide gated channel subunit beta 1 |
| TCMBANKGE000274 | CCL2 | GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF | C-C motif chemokine ligand 2 |
| TCMBANKGE007597 | NOX3 | GP91-3; MOX-2 | NADPH oxidase 3 |
| TCMBANKGE003113 | CX3CL1 | ABCD-3; C3Xkine; CXC3; CXC3C; NTN; NTT; SCYD1; fractalkine; neurotactin | C-X3-C motif chemokine ligand 1 |
| TCMBANKGE000565 | CX3CR1 | CCRL1; CMKBRL1; CMKDR1; GPR13; GPRV28; V28 | C-X3-C motif chemokine receptor 1 |
| TCMBANKGE000093 | IFNB1 | IFB; IFF; IFN-beta; IFNB | interferon beta 1 |
| TCMBANKGE008888 | CHI3L1 | ASRT7; CGP-39; GP-39; GP39; HC-gp39; HCGP-3P; YK-40; YKL-40; YKL40; YYL-40; hCGP-39 | chitinase 3 like 1 |
| TCMBANKGE013090 | DUOX2 | LNOX2; NOXEF2; P138-TOX; TDH6; THOX2 | dual oxidase 2 |
| TCMBANKGE000205 | NOS2 | HEP-NOS; INOS; NOS; NOS2A | nitric oxide synthase 2 |
| TCMBANKGE012155 | SLC6A3 | DAT; DAT1; PKDYS; PKDYS1 | solute carrier family 6 member 3 |
| TCMBANKGE000196 | FAS | ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6 | Fas cell surface death receptor |
| TCMBANKGE014344 | NAT1 | AAC1; MNAT; NAT-1; NATI | N-acetyltransferase 1 |
| TCMBANKGE004935 | FCGR2A | CD32; CD32A; CDw32; FCG2; FCGR2; FCGR2A1; FcGR; IGFR2 | Fc fragment of IgG receptor IIa |
| TCMBANKGE012756 | SLC19A1 | CHMD; FOLT; IFC-1; IFC1; REFC; RFC; RFC1; RFT-1; hRFC; hSLC19A1 | solute carrier family 19 member 1 |
| TCMBANKGE003970 | SDC1 | CD138; SDC; SYND1; syndecan | syndecan 1 |
| TCMBANKGE013197 | FCGR3A | CD16; CD16A; FCG3; FCGR3; FCGRIII; FCR-10; FCRIII; FCRIIIA; IGFR3; IMD20 | Fc fragment of IgG receptor IIIa |
| TCMBANKGE015054 | DUOX1 | LNOX1; NOXEF1; THOX1 | dual oxidase 1 |
| TCMBANKGE014647 | IL7R | CD127; CDW127; IL-7R-alpha; IL7RA; ILRA | interleukin 7 receptor |
| TCMBANKGE007383 | FST | FS | follistatin |
| TCMBANKGE003580 | PDXP | CIN; PLP; dJ37E16.5 | pyridoxal phosphatase |
| TCMBANKGE000611 | CSF2 | CSF; GMCSF | colony stimulating factor 2 |
| TCMBANKGE007141 | MTHFR | - | methylenetetrahydrofolate reductase |
| TCMBANKGE010265 | ISG20 | CD25; HEM45 | interferon stimulated exonuclease gene 20 |
| TCMBANKGE012813 | RGCC | C13orf15; RGC-32; RGC32; bA157L14.2 | regulator of cell cycle |
| TCMBANKGE000663 | AQP4 | MIWC; WCH4 | aquaporin 4 |
| TCMBANKGE001037 | MMP2 | CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1 | matrix metallopeptidase 2 |
| TCMBANKGE000271 | APOE | AD2; APO-E; ApoE4; LDLCQ5; LPG | apolipoprotein E |
| TCMBANKGE000204 | CXCL8 | GCP-1; GCP1; IL8; LECT; LUCT; LYNAP; MDNCF; MONAP; NAF; NAP-1; NAP1; SCYB8 | C-X-C motif chemokine ligand 8 |
| TCMBANKGE014837 | LEPR | CD295; LEP-R; LEPRD; OB-R; OBR | leptin receptor |
| TCMBANKGE001126 | NFE2L2 | HEBP1; IMDDHH; NRF2; Nrf-2 | nuclear factor, erythroid 2 like 2 |
| TCMBANKGE000017 | MAPT | DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU | microtubule associated protein tau |
| TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
| TCMBANKGE000792 | FASLG | ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A | Fas ligand |
| TCMBANKGE000876 | PRDX5 | ACR1; AOEB166; B166; HEL-S-55; PLP; PMP20; PRDX6; PRXV; SBBI10; prx-V | peroxiredoxin 5 |
| TCMBANKGE000199 | ICAM1 | BB2; CD54; P3.58 | intercellular adhesion molecule 1 |
| TCMBANKGE000036 | SOCS1 | CIS1; CISH1; JAB; SOCS-1; SSI-1; SSI1; TIP-3; TIP3 | suppressor of cytokine signaling 1 |
| TCMBANKGE000898 | MYC | MRTL; MYCC; bHLHe39; c-Myc | MYC proto-oncogene, bHLH transcription factor |
| TCMBANKGE003789 | HLA-DQA1 | CELIAC1; DQ-A1; DQA1; HLA-DQA | major histocompatibility complex, class II, DQ alpha 1 |
| TCMBANKGE012841 | HLA-A | HLAA | major histocompatibility complex, class I, A |
| TCMBANKGE001182 | SIRT1 | SIR2; SIR2L1; SIR2alpha | sirtuin 1 |
| TCMBANKGE000971 | MIR20A | C13orf25; MIR17HG; MIR20; MIRH1; MIRHG1; MIRN20; MIRN20A; hsa-mir-20; hsa-mir-20a; miR-20; miRNA20A; mir-20a | microRNA 20a |
| TCMBANKGE000523 | BMP4 | BMP2B; BMP2B1; MCOPS6; OFC11; ZYME | bone morphogenetic protein 4 |
| TCMBANKGE009185 | MEFV | FMF; MEF; TRIM20 | MEFV innate immuity regulator, pyrin |
| TCMBANKGE014448 | FGF23 | ADHR; FGFN; HFTC2; HPDR2; HYPF; PHPTC | fibroblast growth factor 23 |
| TCMBANKGE004769 | UBE2D2 | E2(17)KB2; PUBC1; UBC4; UBC4/5; UBCH4; UBCH5B | ubiquitin conjugating enzyme E2 D2 |
| TCMBANKGE005577 | SEMA3A | COLL1; HH16; Hsema-I; Hsema-III; SEMA1; SEMAD; SEMAIII; SEMAL; SemD; coll-1 | semaphorin 3A |
| TCMBANKGE000751 | TRAF2 | MGC:45012; RNF117; TRAP; TRAP3 | TNF receptor associated factor 2 |
| TCMBANKGE011129 | GH1 | GH; GH-N; GHB5; GHN; IGHD1A; IGHD1B; IGHD2; hGH-N | growth hormone 1 |
| TCMBANKGE000163 | TNFRSF1B | CD120b; TBPII; TNF-R-II; TNF-R75; TNFBR; TNFR1B; TNFR2; TNFR80; p75; p75TNFR | TNF receptor superfamily member 1B |
| TCMBANKGE001158 | LEP | LEPD; OB; OBS | leptin |
| TCMBANKGE009888 | CCL26 | IMAC; MIP-4a; MIP-4alpha; SCYA26; TSC-1 | C-C motif chemokine ligand 26 |
| TCMBANKGE000532 | PECAM1 | CD31; CD31/EndoCAM; GPIIA'; PECA1; PECAM-1; endoCAM | platelet and endothelial cell adhesion molecule 1 |
| TCMBANKGE006020 | UBC | HMG20 | ubiquitin C |
| TCMBANKGE014252 | IL15 | IL-15 | interleukin 15 |
| TCMBANKGE000980 | SOX2 | ANOP3; MCOPS3 | SRY-box transcription factor 2 |
| TCMBANKGE000542 | NLRP1 | AIADK; CARD7; CIDED; CLR17.1; DEFCAP; DEFCAP-L/S; JRRP; MSPC; NAC; NALP1; PP1044; SLEV1; VAMAS1 | NLR family pyrin domain containing 1 |
| TCMBANKGE000422 | MIR15A | MIRN15A; hsa-mir-15a; miRNA15A; mir-15a | microRNA 15a |
| TCMBANKGE000394 | CXCR3 | CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR | C-X-C motif chemokine receptor 3 |
| TCMBANKGE000787 | VCAM1 | CD106; INCAM-100 | vascular cell adhesion molecule 1 |
| TCMBANKGE001065 | KLF4 | EZF; GKLF | Kruppel like factor 4 |
| TCMBANKGE010212 | PSMB8 | ALDD; D6S216; D6S216E; JMP; LMP7; NKJO; PRAAS1; PSMB5i; RING10 | proteasome 20S subunit beta 8 |
| TCMBANKGE002485 | PHEX | HPDR; HPDR1; HYP; HYP1; LXHR; PEX; XLH | phosphate regulating endopeptidase homolog X-linked |
| TCMBANKGE001188 | CXCL10 | C7; IFI10; INP10; IP-10; SCYB10; crg-2; gIP-10; mob-1 | C-X-C motif chemokine ligand 10 |
| TCMBANKGE001119 | S1PR1 | CD363; CHEDG1; D1S3362; ECGF1; EDG-1; EDG1; S1P1 | sphingosine-1-phosphate receptor 1 |
| TCMBANKGE005353 | NLRC4 | AIFEC; CARD12; CLAN; CLAN1; CLANA; CLANB; CLANC; CLAND; CLR2.1; FCAS4; IPAF | NLR family CARD domain containing 4 |
| TCMBANKGE006643 | YWHAZ | 14-3-3-zeta; HEL-S-3; HEL-S-93; HEL4; KCIP-1; POPCHAS; YWHAD | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
| TCMBANKGE000811 | KL | HFTC3 | klotho |
| TCMBANKGE007624 | CD28 | Tp44 | CD28 molecule |
| TCMBANKGE000109 | ACTB | BRWS1; PS1TP5BP1 | actin beta |
| TCMBANKGE001011 | TNFSF10 | APO2L; Apo-2L; CD253; TL2; TNLG6A; TRAIL | TNF superfamily member 10 |
| TCMBANKGE000795 | POU5F1 | OCT3; OCT4; OTF-3; OTF3; OTF4; Oct-3; Oct-4 | POU class 5 homeobox 1 |
| TCMBANKGE012246 | TLR9 | CD289 | toll like receptor 9 |
| TCMBANKGE005843 | TAP2 | ABC18; ABCB3; APT2; D6S217E; PSF-2; PSF2; RING11 | transporter 2, ATP binding cassette subfamily B member |
| TCMBANKGE002000 | CTLA4 | ALPS5; CD; CD152; CELIAC3; CTLA-4; GRD4; GSE; IDDM12 | cytotoxic T-lymphocyte associated protein 4 |
| TCMBANKGE001149 | PPARGC1A | LEM6; PGC-1(alpha); PGC-1alpha; PGC-1v; PGC1; PGC1A; PPARGC1 | PPARG coactivator 1 alpha |
| TCMBANKGE000729 | CASP1 | ICE; IL1BC; P45 | caspase 1 |
| TCMBANKGE008826 | LBR | C14SR; DHCR14B; LMN2R; PHA; PHASK; TDRD18 | lamin B receptor |
| TCMBANKGE001144 | CD14 | - | CD14 molecule |
| TCMBANKGE005662 | ALB | HSA; PRO0883; PRO0903; PRO1341 | albumin |
| TCMBANKGE000668 | ITGB1 | CD29; FNRB; GPIIA; MDF2; MSK12; VLA-BETA; VLAB | integrin subunit beta 1 |
| TCMBANKGE001012 | FOXP3 | AIID; DIETER; IPEX; JM2; PIDX; XPID | forkhead box P3 |
| TCMBANKGE004325 | NR4A2 | HZF-3; NOT; NURR1; RNR1; TINUR | nuclear receptor subfamily 4 group A member 2 |
| TCMBANKGE009742 | HLA-DRB1 | DRB1; HLA-DR1B; HLA-DRB; SS1 | major histocompatibility complex, class II, DR beta 1 |
| TCMBANKGE009543 | LTA | LT; TNFB; TNFSF1; TNLG1E | lymphotoxin alpha |
| TCMBANKGE010270 | APEX1 | APE; APE1; APEN; APEX; APX; HAP1; REF1 | apurinic/apyrimidinic endodeoxyribonuclease 1 |
| TCMBANKGE004205 | PLD1 | CVDD | phospholipase D1 |
| TCMBANKGE004156 | PIAS3 | ZMIZ5 | protein inhibitor of activated STAT 3 |
| TCMBANKGE001041 | ALOX15 | 12-LOX; 15-LOX; 15-LOX-1; LOG15 | arachidonate 15-lipoxygenase |
| TCMBANKGE000007 | IL12B | CLMF; CLMF2; IL-12B; IMD28; IMD29; NKSF; NKSF2 | interleukin 12B |
| TCMBANKGE000240 | IL17A | CTLA-8; CTLA8; IL-17; IL-17A; IL17 | interleukin 17A |
| TCMBANKGE000885 | SPP1 | BNSP; BSPI; ETA-1; OPN | secreted phosphoprotein 1 |
| TCMBANKGE001125 | IGF1 | IGF; IGF-I; IGFI; MGF | insulin like growth factor 1 |
| TCMBANKGE004839 | GEM | KIR | GTP binding protein overexpressed in skeletal muscle |
| TCMBANKGE007850 | CFL1 | CFL; HEL-S-15; cofilin | cofilin 1 |
| TCMBANKGE007998 | TSPO | BPBS; BZRP; DBI; IBP; MBR; PBR; PBS; PKBS; PTBR; mDRC; pk18 | translocator protein |
| TCMBANKGE006405 | CCL11 | SCYA11 | C-C motif chemokine ligand 11 |
| TCMBANKGE001102 | MIR21 | MIRN21; hsa-mir-21; miR-21; miRNA21 | microRNA 21 |
| TCMBANKGE009263 | IL12RB2 | - | interleukin 12 receptor subunit beta 2 |
| TCMBANKGE001108 | BMP2 | BDA2; BMP2A; SSFSC | bone morphogenetic protein 2 |
| TCMBANKGE008717 | PLP1 | GPM6C; HLD1; MMPL; PLP; PLP/DM20; PMD; SPG2 | proteolipid protein 1 |
| TCMBANKGE014942 | NKRF | ITBA4; NRF | NFKB repressing factor |
| TCMBANKGE007547 | BRD2 | BRD2-IT1; D6S113E; FSH; FSRG1; NAT; O27.1.1; RING3; RNF3 | bromodomain containing 2 |
| TCMBANKGE013910 | ERVW-1 | ENV; ENVW; ERVWE1; HERV-7q; HERV-W-ENV; HERV7Q; HERVW; HERVWENV | endogenous retrovirus group W member 1, envelope |
| TCMBANKGE000972 | MIR17 | MIR17-5p; MIR91; MIRN17; MIRN91; hsa-mir-17; miR-17; miR17-3p; miRNA17; miRNA91 | microRNA 17 |
| TCMBANKGE013184 | HP | BP; HP2ALPHA2; HPA1S | haptoglobin |
| TCMBANKGE001001 | SNCA | NACP; PARK1; PARK4; PD1 | synuclein alpha |
| TCMBANKGE007886 | HLA-G | MHC-G | major histocompatibility complex, class I, G |
| TCMBANKGE013076 | CBS | CBSL; HIP4 | cystathionine beta-synthase |
| TCMBANKGE002978 | RTN4R | NGR; NOGOR | reticulon 4 receptor |
| TCMBANKGE001205 | DDIT3 | AltDDIT3; C/EBPzeta; CEBPZ; CHOP; CHOP-10; CHOP10; GADD153 | DNA damage inducible transcript 3 |
| TCMBANKGE012224 | VDR | NR1I1; PPP1R163 | vitamin D receptor |
| TCMBANKGE011576 | NINJ2 | - | ninjurin 2 |
| TCMBANKGE000236 | BDNF | ANON2; BULN2 | brain derived neurotrophic factor |
| TCMBANKGE005378 | KRT20 | CD20; CK-20; CK20; K20; KRT21 | keratin 20 |
| TCMBANKGE007742 | HSPB3 | DHMN2C; HMN2C; HSPL27 | heat shock protein family B (small) member 3 |
| TCMBANKGE000644 | TNFRSF1A | CD120a; FPF; TBP1; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR1; TNFR55; TNFR60; p55; p55-R; p60 | TNF receptor superfamily member 1A |
| TCMBANKGE003207 | MOG | BTN6; BTNL11; MOGIG2; NRCLP7 | myelin oligodendrocyte glycoprotein |
| TCMBANKGE005519 | ENTPD1 | ATPDase; CD39; NTPDase-1; SPG64 | ectonucleoside triphosphate diphosphohydrolase 1 |
| TCMBANKGE004745 | AADAC | CES5A1; DAC | arylacetamide deacetylase |
| TCMBANKGE009929 | SPNS2 | DFNB115; SLC62A2 | sphingolipid transporter 2 |
| TCMBANKGE000143 | POU5F1P4 | OCT3; OCT4; OTF-3; OTF3; Oct-3; Oct-4; Oct4-pg4; POU5F1; POU5FLC1 | POU class 5 homeobox 1 pseudogene 4 |
| TCMBANKGE011523 | HPRT1 | HGPRT; HPRT | hypoxanthine phosphoribosyltransferase 1 |
| TCMBANKGE014322 | IL23A | IL-23; IL-23A; IL23P19; P19; SGRF | interleukin 23 subunit alpha |
| TCMBANKGE000541 | CRYAB | CMD1II; CRYA2; CTPP2; CTRCT16; HEL-S-101; HSPB5; MFM2 | crystallin alpha B |
| TCMBANKGE000350 | PML | MYL; PP8675; RNF71; TRIM19 | PML nuclear body scaffold |
| TCMBANKGE000764 | TRPV1 | VR1 | transient receptor potential cation channel subfamily V member 1 |
| TCMBANKGE007151 | TIMP2 | CSC-21K; DDC8 | TIMP metallopeptidase inhibitor 2 |
| TCMBANKGE007338 | HINT2 | HIT-17 | histidine triad nucleotide binding protein 2 |
| TCMBANKGE012820 | ITGA4 | CD49D; IA4 | integrin subunit alpha 4 |
| TCMBANKGE012228 | DGCR8 | C22orf12; DGCRK6; Gy1; pasha | DGCR8 microprocessor complex subunit |
| TCMBANKGE000075 | IL1RN | DIRA; ICIL-1RA; IL-1RN; IL-1ra; IL-1ra3; IL1F3; IL1RA; IRAP; MVCD4 | interleukin 1 receptor antagonist |
| TCMBANKGE005060 | CD24 | CD24A | CD24 molecule |
| TCMBANKGE000315 | IL4 | BCGF-1; BCGF1; BSF-1; BSF1; IL-4 | interleukin 4 |
滇IICP备16009434号-1 |
Dai SX Lab